Organon & Co

Healthcare · Drug Manufacturers - General

13.70$ +0.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Organon & Co (OGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,558 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement OGN
Line item	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	1,780	1,526	1,613	1,613	1,506	1,618	1,600	1,603	1,567	1,585	1,537	1,485	1,538	1,608	1,519	1,598	1,622	1,607	1,582	1,592	1,513	1,594	1,602	1,507	1,460	1,558	6,127
Cost of Revenue	538	460	535	586	591	583	609	592	561	588	551	585	580	640	612	683	665	668	659	696	672	720	745	748	677	711	2,881
Gross Profit	1,242	1,066	1,078	1,027	915	1,035	991	1,011	1,006	997	986	900	958	968	907	915	957	939	923	896	841	874	857	759	783	847	3,246
Research & Development	45	51	54	60	67	76	111	110	96	106	127	142	129	128	137	134	112	116	111	130	96	95	84	91	93	90	358
Selling, General & Administrative	317	284	321	236	382	416	388	247	371	423	440	213	435	451	497	260	431	437	422	264	420	453	415	433	424	434	1,706
Total Operating Expenses	362	335	375	494	449	492	499	593	467	529	567	610	564	579	675	603	543	553	533	600	516	548	499	524	517	524	2,064
Operating Income	880	731	703	533	466	543	492	418	539	468	419	290	394	389	232	312	414	386	390	296	325	326	358	235	266	323	1,182
Interest Expense	–	0.0	18	8.0	4.0	62	98	98	97	98	108	119	132	132	134	129	131	131	126	132	124	132	128	121	111	108	468
Pre-Tax Income	844	702	681	525	467	437	389	236	442	287	282	111	235	254	80	104	236	235	207	129	101	229	243	-148	213	183	491
Income Tax Expense	110	116	121	149	72	6.0	66	34	94	53	55	3.0	58	12	22	-442	35	40	-152	20	14	84	83	57	67	75	282
Net Income	703	542	547	368	399	427	323	202	348	234	227	108	177	242	58	546	201	195	359	109	87	145	160	-205	146	108	209
EBITDA	913	765	743	568	505	542	539	396	592	435	447	282	424	444	275	293	432	432	402	341	325	449	460	65	410	371	1,306

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings